Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT01051414
First received: January 15, 2010
Last updated: September 23, 2015
Last verified: September 2015